The board of directors of Antengene Corporation Limited announced that Mr. Xubo Hu ("Mr. Hu") has resigned from his office as a non-executive director of the Company with effect from March 26, 2021 to pursue other business and work commitments. In addition, the Board announced that Dr. Kan Chen ("Dr. Chen") has been appointed as a non-executive director of the Company with effect from March 26, 2021. Dr. Kan Chen, aged 39, is currently serving as a Principal at Qiming Venture Partners ("Qiming"), focusing on healthcare investment. Dr. Chen joined Qiming in February 2016, had served as associate and vice president and was deeply involved in Qiming's investment of the Company's series A financing. Dr. Chen has been a director of Connect Biopharma Holdings Limited since December 2020.